Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

4.7K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
4.7K
Humoral Immune Responses01:36

Humoral Immune Responses

88.2K
Overview
88.2K
Antibody Structure01:10

Antibody Structure

69.5K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
69.5K
Immunocytochemistry and Immunohistochemistry01:22

Immunocytochemistry and Immunohistochemistry

15.5K
Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...
15.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling (2026). An international consensus statement on behalf of the ESID/EBMT-IEWP and ERN-RITA.

The Journal of allergy and clinical immunology·2026
Same author

Persisting infections under IgG substitution: Need for further improvement.

Die Pharmazie·2026
Same author

A cross-sectional study of gender differences in quality of life domains in patients with neurofibromatosis type 1.

Orphanet journal of rare diseases·2022
Same author

A rare case of neuro- and otosyphilis in secondary syphilis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

S1 guidelines "lumbar puncture and cerebrospinal fluid analysis" (abridged and translated version).

Neurological research and practice·2020
Same author

Chronic immunoglobulin maintenance therapy in myasthenia gravis.

European journal of neurology·2020
Same journal

The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

Clinical and experimental immunology·2026
Same journal

PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

Clinical and experimental immunology·2026
Same journal

Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

Clinical and experimental immunology·2026
Same journal

Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

Clinical and experimental immunology·2026
Same journal

Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function.

Clinical and experimental immunology·2026
Same journal

Clinical, genetic, and functional characterization of novel NFKB1 variants in Chinese patients with primary immunodeficiency.

Clinical and experimental immunology·2026
See all related articles

Related Experiment Video

Updated: Apr 19, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.6K

7th International Immunoglobulin Conference: Poster presentations.

K Warnatz1, M Ballow, M Stangel

  • 1Centre for Chronic Immunodeficiencies, Freiburg, Germany.

Clinical and Experimental Immunology
|December 30, 2014
PubMed
Summary
This summary is machine-generated.

This study surveyed intravenous and subcutaneous immunoglobulin (IVIg/SCIg) therapy accessibility in Europe. Further research is needed to optimize immunoglobulin therapy efficacy and explore its potential in transplantation.

More Related Videos

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research
05:25

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

Published on: July 14, 2023

2.1K
Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
10:49

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

21.8K

Related Experiment Videos

Last Updated: Apr 19, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.6K
Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research
05:25

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

Published on: July 14, 2023

2.1K
Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
10:49

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens

Published on: January 21, 2019

21.8K

Area of Science:

  • Immunology
  • Pharmacology
  • Clinical Medicine

Background:

  • Immunoglobulin (Ig) therapy, including intravenous (IVIg) and subcutaneous (SCIg) forms, is a primary treatment for primary immunodeficiency disorders (PIDs).
  • The precise mechanisms of action for Ig therapy can vary depending on the specific condition being treated.
  • Emerging clinical observations indicate a need for deeper investigation into the hematological and immunoregulatory effects of therapeutic immunoglobulins.

Purpose of the Study:

  • To assess the accessibility and trends of IVIg/SCIg therapy across Europe.
  • To investigate the potential for optimizing the efficacy of immunoglobulin therapy.
  • To explore the role of individualized dosing regimens for improved patient outcomes.

Main Methods:

  • A pan-European survey was conducted.
  • Data on immunoglobulin therapy accessibility and trends were collected and analyzed.

Main Results:

  • The survey provides valuable insights into the current landscape of IVIg/SCIg therapy availability and usage patterns in Europe.
  • Identified areas where further investigation is required to fully understand the therapeutic effects of immunoglobulins.

Conclusions:

  • Understanding the diverse mechanisms of action and effects of immunoglobulin therapy is crucial for enhancing treatment efficacy.
  • Individualized dosing strategies may lead to better clinical outcomes for patients receiving immunoglobulin therapy.
  • Immunoglobulins show potential in transplantation, meriting further research for future applications.